NASDAQ$BCAB

Bioatla Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Headline financials

Total Revenue

$250K

Previous: $0.00+58275058175.1%
EPS (adj)

-$0.63

Previous: -$1.50+58.0%
Research and development expenses

$16.4M

No prior period
General and administrative expenses

$7.04M

No prior period
Net Income

-$23.4M

No prior period
Operating Income

-$23.5M

No prior period
Cash & Equivalents

$245M

No prior period
Total Assets

$254M

No prior period
Stock-Based Comp

$3.81M

No prior period

Revenue & EPS history

Bioatla · Revenue · Quarterly

$250K

Q4 2021+58,275,058,175.1%vs Q4 2020
Beat estimate in 1 of 5 quarters(20%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+5.5%

Avg return

Earnings day

+4.7%

Avg return

5 days after

+7.5%

Avg return

30 days after

48%

10 / 21 earnings

Positive

+76.7%

Q2 2022

Best reaction

-37.3%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-1.4%-18.1%-15.1%
Q3 2025+23.2%+75.8%+24.8%
Q2 2025-5.6%+3.2%+41.3%
Q1 2025-7.2%-9.1%+1.5%
Q4 2024-4.9%-13.5%+12.2%
Q3 2024+1.9%+6.3%-20.4%
Q2 2024+5.8%+0.7%+25.2%
Q1 2024+13.6%+7.2%-40.5%
Q4 2023+48.5%+47.6%-3.4%
Q3 2023-10.3%-24.2%-15.8%
Q2 2023-0.3%-8.4%-16.1%
Q1 2023+10.9%+7.9%+10.3%
Q4 2022+0.9%+0.4%+48.3%
Q3 2022+17.1%+22.8%+63.1%
Q2 2022+76.7%+86.9%+142.2%
Q1 2022-37.3%-43.9%-28.2%
Q4 2021+1.9%-15.1%-22.8%
Q3 2021-0.3%-1.9%-24.5%
Q2 2021-4.4%-2.7%-9.4%
Q1 2021-2.4%-1.9%+6.6%
Q4 2020-10.6%-21.5%-21.4%
Q3 2020
Q2 2020
Q1 2020
Q4 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro